Selective surface staining of bladder tumors by intravesical methylene blue with enhanced endoscopic identification. (1984)

Peer-Reviewed Study · Gill WB, Huffman JL, Lyon ES, Bagley DH, Schoenberg HW, Straus FH · June 15, 1984

Gill WB et al., 1984-06-15: Intravesical 0.1% methylene blue in saline stained bladder tumours selectively in 45 of 48 patients without staining normal urothelium, and higher-grade tumours bound more dye. The founding human study of MB chromocystoscopy.

Intravesical instillation of methylene blue resulted in selective surface staining of bladder tumors in vivo without staining the background of normal urothelium.

Gill WB et al., 1984-06-15: Intravesical 0.1% methylene blue in saline stained bladder tumours selectively in 45 of 48 patients without staining normal urothelium, and higher-grade tumours bound more dye. The founding human study of MB chromocystoscopy. C9. Study type: prospective diagnostic series. N: 48 patients. Country: USA (Gill WB, Huffman JL, Lyon ES, Bagley DH, Schoenberg HW, Straus FH; Johns Hopkins/NCI surgery group). Methylene blue: 0.1% in 0.9% saline, up to 400 mL, 20 cm hydrostatic pressure, 5 min contact, then saline wash. Funder: PHS P50 AM-20585 (NIADDK). Conflicts: none declared in the record. Comparator: histopathology of the same lesions. Three false negatives had prior chemotherapy. Bears on C9 because the technique is the bladder counterpart of the prostate dye work, and on the general question of MB staining tumour tissue. Study type: uncontrolled series.